SPIB and prostate cancer: For the SNP344 (rs1196333), no association was shown between variants and ovarian, endometrial, breast or prostate cancers, despite in silico data showing that 344A variant seems to modulate the binding of TFAP2A, SPIB and AP1 transcription factors[20].